| GPR30 does not mediate estrogenic responses in reproductive organs in mice C Otto, I Fuchs, G Kauselmann, H Kern, B Zevnik, P Andreasen, ... Biology of reproduction 80 (1), 34-41, 2009 | 315 | 2009 |
| Effects of synthetic gestagens on fish reproduction J Zeilinger, T Steger‐Hartmann, E Maser, S Goller, R Vonk, R Länge Environmental toxicology and chemistry 28 (12), 2663-2670, 2009 | 295 | 2009 |
| History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. K Stark, U Bienzle, R Vonk, I Guggenmoos-Holzmann International journal of epidemiology 26 (6), 1359-1366, 1997 | 176 | 1997 |
| The relevance of placental location at 20–23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases RH Becker, R Vonk, BC Mende, V Ragosch, M Entezami Ultrasound in Obstetrics and Gynecology: The Official Journal of the …, 2001 | 159 | 2001 |
| Doppler sonography of uterine arteries at 20–23 weeks: risk assessment of adverse pregnancy outcome by quantification of impedance and notch R Becker, R Vonk, W Vollert, M Entezami Walter de Gruyter 30 (5), 388-394, 2002 | 93 | 2002 |
| AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection M Rudolph, T Anzeneder, A Schulz, G Beckmann, AT Byrne, M Jeffers, ... BMC cancer 16, 1-12, 2016 | 81 | 2016 |
| Recommendations on the statistical analysis of the Comet assay J Bright, M Aylott, S Bate, H Geys, P Jarvis, J Saul, R Vonk Pharmaceutical statistics 10 (6), 485-493, 2011 | 78 | 2011 |
| Kappa‐like indices of observer agreement viewed from a latent class perspective I Guggenmoos‐Holzmann, R Vonk Statistics in medicine 17 (8), 797-812, 1998 | 63 | 1998 |
| Assessing non‐inferiority of a new treatment in a three‐arm trial in the presence of heteroscedasticity M Hasler, R Vonk, LA Hothorn Statistics in medicine 27 (4), 490-503, 2008 | 60 | 2008 |
| Impaired left-ventricular cardiac function in male GPR30-deficient mice M Delbeck, S Golz, R Vonk, W Janssen, T Hucho, J Isensee, S Schäfer, ... Molecular medicine reports 4 (1), 37-40, 2011 | 55 | 2011 |
| Increasing the efficiency of oncology basket trials using a Bayesian approach R Liu, Z Liu, M Ghadessi, R Vonk Contemporary clinical trials 63, 67-72, 2017 | 51 | 2017 |
| Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate C Otto, I Fuchs, H Altmann, M Klewer, A Walter, K Prelle, R Vonk, ... Endocrinology 149 (8), 3952-3959, 2008 | 37 | 2008 |
| Doppler sonography of uterine arteries at 20–23 weeks: depth of notch gives information on probability of adverse pregnancy outcome and degree of fetal growth restriction in a … R Becker, R Vonk Fetal diagnosis and therapy 27 (2), 78-86, 2010 | 36 | 2010 |
| Redefining the role of biomarkers in heart failure trials: expert consensus document F Kramer, HN Sabbah, JJ Januzzi, F Zannad, J Peter van Tintelen, ... Heart failure reviews 22, 263-277, 2017 | 33 | 2017 |
| Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial. M Teufel, S Schwenke, H Seidel, G Beckmann, J Reischl, R Vonk, ... Journal of clinical oncology 33 (15_suppl), 3558-3558, 2015 | 33 | 2015 |
| In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro C Otto, I Fuchs, H Altmann, M Klewer, G Schwarz, R Bohlmann, D Nguyen, ... The Journal of Steroid Biochemistry and Molecular Biology 111 (1-2), 95-100, 2008 | 29 | 2008 |
| Adverse event analysis and MedDRA: business as usual or challenge? J Kübler, R Vonk, S Beimel, W Gunselmann, M Homering, D Nehrdich, ... Drug information journal 39 (1), 63-72, 2005 | 25 | 2005 |
| The rat bone marrow micronucleus test: Statistical considerations on historical negative control data BW Igl, A Bitsch, F Bringezu, S Chang, M Dammann, R Frötschl, V Harm, ... Regulatory Toxicology and Pharmacology 102, 13-22, 2019 | 19 | 2019 |
| A neutralizing prolactin receptor antibody whose in vivo application mimics the phenotype of female prolactin receptor-deficient mice C Otto, A Särnefält, A Ljungars, S Wolf, B Rohde-Schulz, I Fuchs, ... Endocrinology 156 (11), 4365-4373, 2015 | 19 | 2015 |
| Estradiol release kinetics determine tissue response in ovariectomized rats C Otto, I Kantner, R Nubbemeyer, J Schkoldow, I Fuchs, E Krahl, R Vonk, ... Endocrinology 153 (4), 1725-1733, 2012 | 17 | 2012 |
